Bulletin
Investor Alert

London Markets Open in:

Incyte Corp.

NAS: INCY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/204510994/composite

$

69.75

Change

+0.16 +0.23%

Volume

Volume 80,676

Sep 22, 2021, 7:51 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/204510994/composite

Today's close

$ 76.06

$ 69.59

Change

-6.47 -8.51%

Day low

Day high

$69.42

$73.85

Open
Open: 73.12

52 week low

52 week high

$69.42

$101.47

Open

Market cap

$16.80B

Average volume

1.30M

P/E ratio

45.73

Rev. per Employee

$1.50M

EPS

1.52

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/incy

MarketWatch News on INCY

  1. Incyte Corp. stock underperforms Wednesday when compared to competitors

    5:00 p.m. Today

    - MarketWatch Automation

  2. Stocks Snap Their Losing Streak After Fed Talks Tapering, Rates, and Inflation

    4:27 p.m. Today

    - Barron's Online

  3. Incyte gets FDA approval for atopic dermatitis drug

    8:59 a.m. Today

    - Jaimy Lee

  4. Incyte Corp. stock outperforms competitors on strong trading day

    5:00 p.m. Sept. 21, 2021

    - MarketWatch Automation

  5. Incyte Corp. stock underperforms Monday when compared to competitors

    5:00 p.m. Sept. 20, 2021

    - MarketWatch Automation

  6. The Stock Market Is Tanking. These 5 Stocks Are Not.

    1:23 p.m. Sept. 20, 2021

    - Barron's Online

  7. Incyte Corp. stock outperforms market on strong trading day

    5:00 p.m. Sept. 17, 2021

    - MarketWatch Automation

  8. Incyte Corp. stock outperforms market on strong trading day

    5:01 p.m. Sept. 16, 2021

    - MarketWatch Automation

  9. Incyte Corp. stock outperforms competitors on strong trading day

    5:00 p.m. Sept. 15, 2021

    - MarketWatch Automation

  10. Incyte Corp. stock falls Tuesday, still outperforms market

    4:59 p.m. Sept. 14, 2021

    - MarketWatch Automation

  11. Incyte Corp. stock rises Monday, outperforms market

    5:00 p.m. Sept. 13, 2021

    - MarketWatch Automation

  12. Incyte Corp. stock falls Friday, underperforms market

    5:00 p.m. Sept. 10, 2021

    - MarketWatch Automation

  13. Incyte Corp. stock underperforms Thursday when compared to competitors

    5:00 p.m. Sept. 9, 2021

    - MarketWatch Automation

  14. Incyte Corp. stock falls Wednesday, underperforms market

    5:00 p.m. Sept. 8, 2021

    - MarketWatch Automation

  15. Incyte Corp. stock underperforms Tuesday when compared to competitors

    5:00 p.m. Sept. 7, 2021

    - MarketWatch Automation

  16. Active Funds Are Doing Better. This Is What's Helping Them.

    1:12 p.m. Sept. 7, 2021

    - Barron's Online

  17. Incyte Corp. stock falls Friday, underperforms market

    5:00 p.m. Sept. 3, 2021

    - MarketWatch Automation

  18. Incyte Corp. stock rises Thursday, still underperforms market

    5:00 p.m. Sept. 2, 2021

    - MarketWatch Automation

  19. Incyte Corp. stock outperforms market on strong trading day

    5:00 p.m. Sept. 1, 2021

    - MarketWatch Automation

  20. Loading more headlines...
/news/nonmarketwatch/company/us/incy

Other News on INCY

  1. FDA approves Incyte's Jakafi in chronic graft-versus-host disease indication

    12:48 p.m. Today

    - Seeking Alpha

  2. Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start

    11:36 a.m. Today

    - Motley Fool

  3. Incyte (INCY) Ruxolitinib Cream Wins FDA Nod for Atopic Dermatitis

    8:29 a.m. Today

    - Zacks.com

  4. Incyte trades lower on safety warning in FDA approval for Opzelura

    7:13 a.m. Today

    - Seeking Alpha

  5. FDA approves Incyte's atopic dermatitis treatment Opzelura

    4:18 p.m. Sept. 21, 2021

    - Seeking Alpha

  6. Is AbbVie a Bad News Buy?

    11:01 a.m. Sept. 19, 2021

    - Motley Fool

  7. Wall Street Breakfast: The Week Ahead (Podcast)

    7:28 a.m. Sept. 19, 2021

    - Seeking Alpha

  8. Wall Street Breakfast: The Week Ahead

    7:17 a.m. Sept. 19, 2021

    - Seeking Alpha

  9. AstraZeneca lung cancer data propel Corvus and Arcus

    10:43 a.m. Sept. 17, 2021

    - Seeking Alpha

  10. Is QQQ Overvalued Or Undervalued?

    8:01 a.m. Sept. 14, 2021

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/incy

Press Releases on INCY

  1. Top Stocks To Watch This Week? 4 Biotech Stocks To Know

    10:38 p.m. July 15, 2021

    - StockMarket.com

  2. Incyte to Report Second Quarter Financial Results

    8:00 a.m. July 15, 2021

    - BusinessWire - BZX

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.